In an ALS study, growth factor FGF4 reduced the activity of star-shaped cells called astrocytes but did not stop motor ...

Living with ALS is easier with six tried-and-tested everyday habits, columnist Dagmar Munn has found. Among them: dressing well.

Differences in human tears in ALS can distinguish bulbar-onset disease from spinal-onset ALS, making this a possible ...

Modality.AI and Target ALS are partnering on a clinical study of AI as a way to assess changes in speech and motor function ...

Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...

The new patent covers Neurosense's formulation of PrimeC, a fixed-dose combo of an approved antibiotic and anti-inflammatory.

ProJenX teamed with Unlearn to create digital twins of ALS patients as a placebo group in open-label extension of Phase 1 ...

Columnist Juliet Taylor chats with Roon CEO and co-founder Vikram Bhaskaran about this new ALS app designed for patients and ...

Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...

A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...

The Mayo Clinic was awarded $12 million to support a study that will give ALS patients access to the investigational therapy ...

Kristin Neva is an author, mother of two, and caregiver for her husband, Todd, who was diagnosed with ALS in 2010 when he was 39 years old. Knowing they would need family support, they moved to Upper ...